Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study
Grégoire Le Meur(Lyon 1 Université), Maël Heiblig(Université Claude Bernard Lyon 1), Marie Balsat(Hôpital Claude Huriez), Adriana Pleșa(Hospices Civils de Lyon), Sandrine Loron(Hôpital de la Croix-Rousse), Fiorenza Barraco(Hôpital Lyon Sud), Rubio Marie Thérèse(Centre National de la Recherche Scientifique), Xavier Thomas(Hôpital Lyon Sud), Marie‐Virginie Larcher, Isabelle Tigaud(Inserm), Hervé Ghesquières(Université Claude Bernard Lyon 1), Gaëlle Fossard(Hospices Civils de Lyon), Myriam Renault(Hospices Civils de Lyon), Sandrine Hayette(Lyon 1 Université), Sarah Huet(Inserm), Pierre Sujobert(Université Claude Bernard Lyon 1), Hélène Labussière‐Wallet(Hospices Civils de Lyon), Mauricette Michallet(Institut d’Hématologie et d’Oncologie Pédiatrique), Sophie Ducastelle-Leprêtre(Hospices Civils de Lyon), Lila Gilis(Hospices Civils de Lyon)
Cited by 10
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547